1. Canada Stocks

  2. •

    Financial Services

  3. •

    Financial - Conglomerates
Pharmacorp Rx Inc.

Pharmacorp Rx Inc.

PCRX.V
Pharmacorp Rx Inc.CA flagToronto Stock Exchange Ventures
0.42
CAD
+0.03
- -
82.38MMarket Cap

Total Valuation

Pharmacorp Rx Inc. carries a market capitalization of 82.38M, placing it among publicly traded companies globally. Its enterprise value stands at 67.85M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap82.38M
Enterprise Value67.85M

Share Statistics

Pharmacorp Rx Inc. currently has 174.08M shares outstanding.

Shares Outstanding174.08M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Pharmacorp Rx Inc. trades at a trailing price-to-earnings ratio of 275.75. The price-to-sales ratio is 2.83, and the price-to-book ratio stands at 1.65.

PE Ratio275.75
PS Ratio2.83
PB Ratio1.65
P/TBV Ratio3.83
P/FCF Ratio193.85
P/OCF Ratio337.96

Enterprise Valuation

On an enterprise value basis, Pharmacorp Rx Inc. trades at an EV/EBITDA multiple of 101.02 and an EV/FCF ratio of 103.82.

EV / Sales2.48
EV / EBITDA101.02
EV / EBITN/A
EV / FCF103.82

Financial Position

Pharmacorp Rx Inc. maintains a current ratio of 7.36, meaning it holds 7.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.33, indicating elevated leverage, while an interest coverage ratio of -0.32 demonstrates limited ability to service its debt obligations.

Current Ratio7.36
Quick Ratio6.53
Debt / Equity8.33
Debt / EBITDA-79.28
Interest Coverage-0.32

Financial Efficiency

Return on Equity (ROE)-2.75
Return on Assets (ROA)-2.29
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover6.88

Taxes

Income Tax279,332.00
Effective Tax RateN/A

Stock Price Statistics

Pharmacorp Rx Inc.'s stock has declined approximately -8.69565% over the past 52 weeks. The 50-day moving average sits at 0.48, while the 200-day moving average is 0.47.

Beta (5Y)N/A
52-Week Price Change-8.69565%
50-Day Moving Average0.48
200-Day Moving Average0.47
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Pharmacorp Rx Inc. generated 27.41M in revenue and converted that into -1.14M in net income, yielding earnings per share of -0.01. EBITDA reached -55,850.00, while operating income came in at -1.31M.

Revenue27.41M
Gross Profit10.83M
Operating Income-1.31M
Pretax Income-763,155.00
Net Income-1.14M
EBITDA-55,850.00
EBIT-1.31M
Earnings Per Share (EPS)-0.01

Balance Sheet

Pharmacorp Rx Inc. holds 24.01M in cash and equivalents against 4.43M in total debt, resulting in a net debt position of -20.57M. Total book value stands at 52.77M, with working capital of 24.95M providing operational flexibility.

Cash & Cash Equivalents24.01M
Total Debt4.43M
Net Debt-20.57M
Equity (Book Value)52.77M
Book Value Per Share0.30
Working Capital24.95M

Cash Flow

Pharmacorp Rx Inc. produced 229,546.00 in operating cash flow over the past twelve months. After subtracting -186,598.00 in capital expenditures, free cash flow totaled 42,948.00 - equivalent to 0.00 per share.

Operating Cash Flow229,546.00
Capital Expenditures-186,598.00
Free Cash Flow42,948.00
FCF Per Share0.00

Margins

Pharmacorp Rx Inc. operates with a gross margin of 39.53, reflecting its pricing power and cost economics. The operating margin of -4.77 and net profit margin of -4.16 provide insight into operational efficiency.

Gross Margin39.53
Operating Margin-4.77
Pretax Margin-2.78
Profit Margin-4.16
EBITDA Margin-0.20

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-29.03
FCF Yield0.52

Scores

Pharmacorp Rx Inc. posts an Altman Z-Score of 6.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.12